How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

  • Question on Consultation

    Has all of the relevant evidence been taken into account?

  • Question on Consultation

    Are the summaries of clinical and and cost effectiveness reasonable interpretations of the evidence?

  • Question on Consultation

    Are the recommendations sound and a suitable basis for guidance to the NHS?

  • Question on Consultation

    Are there any equality issues that need special consideration and are not covered in the medical technology consultation document?

  • Question on Document

    Is there any ongoing study in addition to the REINFORCE trial and the MASTERY cohort study that we may have missed and could be used to address any evidence gaps?
The content on this page is not current guidance and is only for the purposes of the consultation process.

Evidence generation plan

Closed for comments This consultation ended on at   Request commenting lead permission

5 Minimum evidence standards

All the technologies that have been recommended for use in the NHS while more evidence is generated have some clinical evidence suggesting that they are comparable with current standard of care for primary patient-level outcomes and have some resource use costs and implementation experience in the NHS. None of the technologies reported any safety concerns.

In addition to this evidence, the committee has indicated that it may be able to recommend technologies in this topic area in the future that have evidence for:

  • the learning curve for healthcare professionals using the technology

  • the impact of the technology on resource use in the NHS

  • the impact of the technology on clinical outcomes.

Companies can strengthen the evidence base by also having qualitative evidence about healthcare professional opinion, procedure-related discomfort, and ergonomics of the RAS technology for the surgeon.

Comments panel open